ADPT today
$28.94-$1.00 (-3.34%)close Nov 12, 2026Trend
DailyDowntrend (starting)
4 hourStrong Bullish
1 hourBearish
15 minStrong Bearish
5 minBearish
Daily trend turns up above $30.74
Key levels
Resistance$31.80
Resistance$29.05
Support$27.14
Support$24.80
Latest news & SEC filings
NewsAdaptogenics Health Corp. moves up to OTCQB Venture Market
SEC FilingAdaptive Biotechnologies Corp filed an insider trading report (Form 4)
AnalystGuggenheim keeps Buy rating on Adaptive Biotechnologies, lifts target to $34
All ADPT news →About Adaptive Biotechnologies
Adaptive Biotechnologies is a healthcare company that uses immune system sequencing to develop diagnostics and research services. It operates two main businesses: one focused on minimal residual disease testing for blood cancers, and another that sequences immune receptors and maps them to antigens for drug discovery. Its main product is the clonoSEQ test, sold to clinicians and biopharmaceutical partners. The company operates primarily in the United States.
Based on the company's 10-K filed Feb 26, 2026.
Nasdaq · Healthcare
Adaptive Biotechnologies Corp (ADPT)
What Is the Price Target for ADPT?
SEPT Low Target
$22.00
SEPT Mid Target
$32.00
SEPT High Target
$35.00
Analyst Consensus
$32.00
Is ADPT a Buy or Sell Right Now?
Thesis
- •Revenue growing 54.8% YoY with ACCELERATING trend — accelerating momentum.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for ADPT.
Start Free Trial →Is ADPT Overvalued or Undervalued?
Valuation Verdict
OVERVALUED
Methods Used
P/B, Analyst Consensus
Fair Value
$24.61
21
Moat Score
NONE
5/9
Piotroski Score
6.5
Altman Z-Score
What Is Smart Money Doing with ADPT?
Insider Signal
SELLING
0 buys / 13 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| RUBINSTEIN JULIE | officer | Buy | 11,881 | $144K | Nov 10, 2026 |
| RUBINSTEIN JULIE | officer | Sale | 9,981 | $293K | Nov 10, 2026 |
| RUBINSTEIN JULIE | officer | Sale | 1,900 | $58K | Nov 10, 2026 |
| RUBINSTEIN JULIE | officer | Buy | 11,881 | $144K | Nov 9, 2026 |
| RUBINSTEIN JULIE | officer | Sale | 1,100 | $32K | Nov 9, 2026 |
| RUBINSTEIN JULIE | officer | Sale | 8,381 | $253K | Nov 9, 2026 |
| RUBINSTEIN JULIE | officer | Sale | 2,400 | $73K | Nov 9, 2026 |
| RUBINSTEIN JULIE | officer | Buy | 11,881 | $144K | Nov 6, 2026 |
| RUBINSTEIN JULIE | officer | Sale | 8,400 | $229K | Nov 6, 2026 |
| RUBINSTEIN JULIE | officer | Sale | 3,481 | $97K | Nov 6, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →ADPT Growth Story
Revenue YoY
54.8%
3yr Revenue CAGR
14.3%
EPS Growth YoY
63.89%
FCF Growth YoY
50.5%
Revenue Trend
ACCELERATING
Dark Pool Trades for ADPT
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for ADPT, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 14:32:55 | $29.32 | 1,500 | $$44K | BUY |
| 14:30:20 | $29.13 | 1,390 | $$40K | BUY |
| 14:30:04 | $28.59 | 1,145 | $$33K | SELL |
| 22:25:45 | $29.94 | 15,444 | $$462K | SELL |
| 21:00:46 | $29.94 | 1,224 | $$37K | SELL |
5 dark pool trades shown · $$616K preview volume
Real-time institutional flow, block trades, and net positioning
Options Flow for ADPT
PREVIEWSEPT Investing provides real-time options flow tracking for ADPT, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| PUT | $12.5 | Apr 16 | 155 | $$2000 | 100 | BLOCK |
1 options trades shown · 0% calls
Unusual activity, GEX levels, max pain, and dealer positioning
What Traders Are Saying About ADPT
3 postsSEPT Investing hosts an active community of 3,500+ traders sharing real-time analysis, trade setups, and market discussion for ADPT. Join verified traders discussing price action, dark pool alerts, options flow, and AI-powered market intelligence.
Smart Money Moves $MOMO — Qi Dave | Sale $INM — ADAR1 Capital Management, LLC | Sale $3K $ADPT — RUBINSTEIN JULIE | Sale $144K $ADPT — RUBINSTEIN JULIE | Sale $305K $GDYN — Gryzlov Yury | Sale $39K
Zone Setup -- $ADPT (Adaptive Biotechnologies Corp) Price: $19.34 | Zone: $15.90 to $19.74 Conviction: HIGH | Analyst upside: +16.1% Near resistance (90% of range) — breakout watch. Strong positive ...
Zone Setup -- $ADPT (Adaptive Biotechnologies Corp) Price: $18.11 | Zone: $15.96 to $18.13 Conviction: MEDIUM | Analyst upside: +10.4% Major volume event today — setup forming. Positive news (2+ vs ...
Join 3,500+ traders discussing ADPT in real-time
Trade ideas, setups, dark pool alerts, and AI-powered analysis
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Adaptive Biotechnologies Corp (ADPT) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →ADPT — frequently asked questions
What is ADPT stock price today?
Adaptive Biotechnologies Corp (ADPT) is at $28.94, down 3.34% (-$1.00) at the Nov 12, 2026 close.
Why is ADPT stock moving today?
Latest ADPT news — Nov 11, 2026: Adaptogenics Health Corp. moves up to OTCQB Venture Market · Nov 10, 2026: Adaptive Biotechnologies Corp filed an insider trading report (Form 4)
What is the ADPT price target?
The average analyst price target for ADPT is $32.00, ranging from $22 to $35, based on 7 analysts. Latest: Guggenheim maintains on Nov 10, 2026.
What do analysts rate ADPT?
Analyst ratings for ADPT: 0 Buy, 16 Hold, 0 Sell — consensus Hold.
Did ADPT beat earnings?
ADPT last reported on Nov 4, 2026: EPS $0.02 vs -$0.09 expected — a beat of 122.0%.
Does ADPT pay a dividend?
ADPT does not currently pay a dividend.
What are ADPT support and resistance levels?
Support: $27.14, $24.80, $21.74. Resistance: $29.05, $31.80, $33.69.
What are insiders doing with ADPT?
Insider activity: SELLING, 0 buys and 13 sells in the last 90 days.
What is the latest news on ADPT?
Nov 11, 2026: Adaptogenics Health Corp. moves up to OTCQB Venture Market · Nov 10, 2026: Adaptive Biotechnologies Corp filed an insider trading report (Form 4) · Nov 10, 2026: Guggenheim keeps Buy rating on Adaptive Biotechnologies, lifts target to $34